Concepedia

Author

Ariane Dienst

Heinrich Heine University Düsseldorf

Also Known As

A Dienst, A. Dienst, Ariane Dienst

49

Publications

707

Citations

11

H-Index

13

Concepts

All Affiliations

Heinrich Heine University DüsseldorfGoethe University FrankfurtDüsseldorf University HospitalEssen University HospitalUniversity of Göttingen
AD

About

Ariane Dienst is an author at Heinrich Heine University Düsseldorf specializing in medicine, oncology, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

131

2

Health Sciences

1

1

29

3

Immunology

1

1

75

4

Marrow Transplantation

1

1

29

5

Molecular Medicine

1

1

75

Ariane Dienst

×

10

Publications

583

Citations

10

H-Index

YearCitations

Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions—A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

Thomas Schroeder, Elena Rachlis, Gesine Bug,

Biology of Blood and Marrow Transplantation

2014

198

Specific Occlusion of Murine and Human Tumor Vasculature by VCAM-1–Targeted Recombinant Fusion Proteins

Ariane Dienst, Andrea Grunow, Maike Unruh,

JNCI Journal of the National Cancer Institute

2005

86

Sorafenib (Nexavar®) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia

Nancy Safaian, Akos Czibere, Ingmar Bruns,

Leukemia Research

2008

75

Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid

A. Kuendgen, Gesine Bug, Oliver G. Ottmann,

Clinical Epigenetics

2011

47

Sorafenib and azacitidine as salvage therapy for relapse of <scp>FLT</scp>3‐<scp>ITD</scp> mutated <scp>AML</scp> after allo‐<scp>SCT</scp>

Christina Rautenberg, Kathrin Nachtkamp, Ariane Dienst,

European Journal Of Haematology

2016

47

Wilms' Tumor 1 Gene Expression Using a Standardized European LeukemiaNet-Certified Assay Compared to Other Methods for Detection of Minimal Residual Disease in Myelodysplastic Syndrome and Acute Myelogenous Leukemia after Allogeneic Blood Stem Cell Transplantation

Christina Rautenberg, Sabrina Pechtel, Barbara Hildebrandt,

Biology of Blood and Marrow Transplantation

2018

47

Relapse patterns and treatment strategies in patients receiving allogeneic hematopoietic stem cell transplantation for myeloid malignancies

Esther Schuler, Sarah Boughoufala, Christina Rautenberg,

Annals of Hematology

2019

29

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Andreas Hüttmann, Jan Rekowski, Stefan Müller,

Annals of Hematology

2019

27

Soluble Tissue Factor Induces Coagulation on Tumor Endothelial Cells In Vivo if Coadministered With Low-Dose Lipopolysaccharides

Jana Philipp, Ariane Dienst, Maike Unruh,

Arteriosclerosis Thrombosis and Vascular Biology

2003

15

Treatment of Poor Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia with a Combination of 5-Azacytidine and Valproic Acid

A. Kuendgen, Gesine Bug, Oliver G. Ottmann,

Blood

2008

12

Page 1